share_log

Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership

Institutional Investors Have a Lot Riding on APT Medical Inc. (SHSE:688617) With 37% Ownership

機構投資者對擁有37%所有權的APT Medical Inc.(上海證券交易所代碼:688617)大加讚賞
Simply Wall St ·  02/12 19:14

Key Insights

關鍵見解

  • Significantly high institutional ownership implies APT Medical's stock price is sensitive to their trading actions
  • A total of 5 investors have a majority stake in the company with 51% ownership
  • Insiders own 36% of APT Medical
  • 高機構所有權意味着APT Medical的股價對其交易行爲很敏感
  • 共有5名投資者持有該公司的多數股權,所有權爲51%
  • 業內人士擁有APT Medical36%的股份

To get a sense of who is truly in control of APT Medical Inc. (SHSE:688617), it is important to understand the ownership structure of the business. With 37% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

要了解誰真正控制了APT Medical Inc.(上海證券交易所代碼:688617),了解該業務的所有權結構非常重要。機構擁有37%的股份,是公司的最大股份。換句話說,該集團面臨最大的上行潛力(或下行風險)。

Last week's 7.0% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. One-year return to shareholders is currently 26% and last week's gain was the icing on the cake.

上週7.0%的漲幅意味着,儘管該公司表現出強勁的長期趨勢,但機構投資者仍處於積極的一端。目前,一年股東回報率爲26%,上週的漲幅錦上添花。

Let's delve deeper into each type of owner of APT Medical, beginning with the chart below.

讓我們從下圖開始,深入研究APT Medical的每種類型的所有者。

ownership-breakdown
SHSE:688617 Ownership Breakdown February 13th 2024
SHSE: 688617 所有權明細 2024 年 2 月 13 日

What Does The Institutional Ownership Tell Us About APT Medical?

關於APT Medical,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

We can see that APT Medical does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at APT Medical's earnings history below. Of course, the future is what really matters.

我們可以看到,APT Medical確實有機構投資者;他們持有該公司很大一部分股票。這意味着在這些機構工作的分析師已經看過這隻股票,他們很喜歡。但是就像其他人一樣,他們可能錯了。如果多家機構同時改變對股票的看法,你可能會看到股價快速下跌。因此,值得在下面查看APT Medical的收益記錄。當然,未來才是真正重要的。

earnings-and-revenue-growth
SHSE:688617 Earnings and Revenue Growth February 13th 2024
SHSE: 688617 收益和收入增長 2024 年 2 月 13 日

APT Medical is not owned by hedge funds. The company's CEO Zhenghui Cheng is the largest shareholder with 33% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 6.2% and 4.6%, of the shares outstanding, respectively.

APT Medical不歸對沖基金所有。該公司首席執行官程正輝是最大股東,已發行股份的33%。同時,第二和第三大股東分別持有已發行股份的6.2%和4.6%。

To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

爲了使我們的研究更有趣,我們發現前五名股東控制着公司一半以上的股份,這意味着該集團對公司的決策具有相當大的影響力。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解風向哪個方向吹來也是有意義的。有相當數量的分析師在報道該股,因此了解他們對未來的總體看法可能很有用。

Insider Ownership Of APT Medical

APT Medical 的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間確實有所不同。我們的數據反映了個人內部人士,至少涵蓋了董事會成員。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

Our information suggests that insiders maintain a significant holding in APT Medical Inc.. Insiders own CN¥11b worth of shares in the CN¥30b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

我們的信息表明,內部人士持有APT Medical Inc.的大量股份。內部人士擁有這家300億元人民幣公司價值110億元人民幣的股份。這很有意義。大多數人會說,這表明了與股東的良好一致性,尤其是在如此規模的公司中。你可以點擊這裏查看這些內部人士是否在買入或賣出。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 15% stake in APT Medical. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

公衆通常是個人投資者,持有APT Medical15%的股份。這種所有權規模雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 12%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據表明,私營公司持有公司12%的股份。私人公司可能是關聯方。有時,內部人士通過控股私營公司而不是以個人身份對上市公司感興趣。雖然很難得出任何廣泛的中風結論,但值得注意的是,這是一個需要進一步研究的領域。

Next Steps:

後續步驟:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

雖然值得考慮擁有公司的不同群體,但還有其他更爲重要的因素。

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

我喜歡更深入地了解一家公司過去的表現。您可以免費訪問這張過去的收益、收入和現金流的交互式圖表。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,您可以查看這份免費報告,其中顯示了分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論